RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific reports, 2020 - nature.com
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …

Does PET-CT have a role in the evaluation of tuberculosis treatment in phase 2 clinical trials?

GB Cross, J O'Doherty, CC Chang… - The Journal of …, 2024 - academic.oup.com
Positron emission tomography–computed tomography (PET-CT) has the potential to
revolutionize research in infectious diseases, as it has done with cancer. There is growing …

Advances in the diagnosis and treatment of latent tuberculosis infection

YEG Jung, NW Schluger - Current opinion in infectious diseases, 2020 - journals.lww.com
Advances in the diagnosis and treatment of latent tuberculos... : Current Opinion in Infectious
Diseases Advances in the diagnosis and treatment of latent tuberculosis infection : Current …

Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response

ST Malherbe, RY Chen, P Dupont, I Kant, M Kriel… - EJNMMI research, 2020 - Springer
Background There is a growing interest in the use of F-18 FDG PET-CT to monitor
tuberculosis (TB) treatment response. Tuberculosis lung lesions are often complex and …

PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment

GB Cross, IP Sari, SM Burkill, CW Yap… - Nature …, 2024 - nature.com
Adjunctive rosuvastatin for rifampicin-susceptible pulmonary tuberculosis (rs-PTB) shows no
effect on microbiological or radiological outcomes in a phase IIb randomised, controlled trial …

Investigating non-sterilizing cure in TB patients at the end of successful anti-TB therapy

CGG Beltran, T Heunis, J Gallant, R Venter… - Frontiers in cellular …, 2020 - frontiersin.org
Mycobacterium tuberculosis (Mtb) is extremely recalcitrant to antimicrobial chemotherapy
requiring 6 months to treat drug-sensitive tuberculosis (TB). Despite this, 4–10% of cured …

Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis

S Meier, JA Seddon, E Maasdorp, L Kleynhans… - PloS one, 2022 - journals.plos.org
Mycobacterium tuberculosis (M. tb) causes tuberculosis (TB) and remains one of the leading
causes of mortality due to an infectious pathogen. Host immune responses have been …

Comparing gene expression profiles of adults with isolated spinal tuberculosis to disseminated spinal tuberculosis identified by 18FDG-PET/CT at time of diagnosis, 6 …

J Scherer, SL Mukasa, K Wolmarans, R Guler… - Journal of Orthopaedic …, 2024 - Springer
Background Tuberculosis (TB) is one of the top ten causes of death worldwide, with
approximately 10 million cases annually. Focus has been on pulmonary TB, while …

The peripheral blood transcriptome is correlated with PET measures of lung inflammation during successful tuberculosis treatment

T Odia, ST Malherbe, S Meier, E Maasdorp… - Frontiers in …, 2021 - frontiersin.org
Pulmonary tuberculosis (PTB) is characterized by lung granulomas, inflammation and tissue
destruction. Here we used within-subject peripheral blood gene expression over time to …

Risk Factors of Tuberculosis Destroyed Lung in Patients with Pulmonary Tuberculosis and Structural Lung Diseases: A Retrospective Observational Study

L Liu, X Wang, L Luo, X Liu, J Chen - Risk Management and …, 2024 - Taylor & Francis
Background Tuberculosis destroyed lung constitutes a significant worldwide public health
challenge, little is known about its associated risk factors and prognosis. Our study aimed to …